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Background: Garcinol is a polyisoprenylated benzophenone derivative present in the fruit rinds of Garcinia 
species namely Garcinia indica (common name 'Kokum') and Garcinia cambogia (common name 'Gombogee'). It 
appears to be involved in the regulation of oxidative stress and antioxidant capacity of heart tissue when the 
heart is subjected to oxidative stress in various pathogenic conditions/ chemical agent. But garcinol is 
associated with severe limitation of instability and poor bioavailability which can be improved complexing 
cyclodextrin with garcinol (garcinol complex). Objective: The objective of the present study was to investigate 
effect of cyclodextrin with garcinol complex (20 mg/kg), on Iso induced cardiotoxicity and cardiac hypertrophy in 
rats.Methods: Male Wistar rats (250-300g) were divided into following 4 groups of six animals each. Group 1 
was control (distilled water 2 ml/kg/day orally for 18 days and water for injection by i.p. from day 9 to day 
18), group 2 was cyclodextrin (cyclodextrin 2 ml/kg/day orally for 18 days and water for injection by i.p. from 
day 9 to day 18), group 3 Iso (distilled water 2 ml/kg/day orally for 18 days and isoproterenol 1 mg/kg by 
i.p. from day 9 to day 18), group 4 garcinol complex  (20 mg/kg/day orally for 18 days and isoproterenol 1 
mg/kg by i.p. from day 9 to day 18). After 24 hrs of last dose of isoproterenol, electrocardiogram (ECG) and 
heart rate were recorded in anaesthetized rats. The animals were sacrificed by overdose of ether. The hearts 
of animals were isolated for measurement of reduced glutathione (GSH) and lipid peroxidation (MDA). Results: 
Isoproterenol treated rats showed significant myocardial hypertrophy, decreased endogenous antioxidants when 
compared with the control group animals. The garcinol complex (20 mg/kg) treatment for 18 days showed 
significant cardioprotective activity by lowering the myocardial hypertrophy, level of lipid peroxidation (MDA 
content) as well as elevated the level of GSH. The results suggest pre-treatment of garcinol complex (20 
mg/kg), may offer potential benefits in the management of cardiotoxicity and cardiac hypertrophy. Conclusion: It 
is thus concluded that Garcinol Complex (20 mg/kg) administration offered significant protection against 
isoproterenol induced cardiotoxicity and cardiac hypertrophy as well as decreased myocardial injury by 
preservation of endogenous antioxidants and reduction of lipid peroxidation in rat heart. 
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Introduction 
Cardiac hypertrophy is an adaptive response 
of heart muscle to a wide variety of intrinsic and 
extrinsic stimuli. It is defined as a physiological and 
pathological condition associated with changes in size, 
shape and function of heart. Although hypertrophy of 
the heart muscle is initially beneficial during early 
growth, but prolonged hypertrophy is potentially 
deleterious causing dilated cardiomyopathy and heart 
failure. It is a predictor of cardiovascular morbidity 
and mortality, independent of hypertension and 
coronary diseases.1, 2 
Oxidative stress is one of the most important 
factors involved in pathological cardiac hypertrophy, 
some chemicals like isoproterenol are well known to 
generate free radicals and  stimulate lipid peroxidation 
(LPO), which is a causative factor for irreversible 
damage to the myocardial membrane resulting in 
infract like necrosis and leads to deposition of lipids in 
myocardial muscles.3,4,5   
The literature shows that chalcones having 
antioxidant, anti-inflammatory property can reverse 
the oxidative stress produced by various chemicals, 
pathogenic conditions and sedentary life style.6,7 
Garcinol is a polyisoprenylated benzophenone 
derivative present in the fruit rinds of Garcinia species 
namely Garcinia indica (common name 'Kokum') and 
Garcinia cambogia (common name 'Gombogee'). It is 
a potent antioxidant  has a limitation of poor stability 
and bioavailability.8 There are several methods to 
improve these limitations and complexation is one of 
them.  
Literature shows that cyclodextrin is a (α-1, 
4)-linked α-D-glucopyranose unit, which is able to 
form inclusion complexes with many drugs by taking 
up the drug molecule into the central cavity. No 
Effect of cyclodextrin garcinol complex on isoproterenol -
induced cardiotoxicity and cardiac hypertrophy in rats 
 
Effect of cyclodextrin garcinol complex …                                                                                                                                                                                                 Kushawaha et al. 




covalent bonds are formed or broken during complex 
formation. The complexed drug molecule remains in 
rapid equilibrium with free solvated and complexed 
forms in the solution. The complexation of garcinol 
with cyclodextrin is reported in literature. Cyclodextrin 
enhances the drug permeability by direct action on the 
biological membrane. It also increases the garcinol 
stability by restricting the drug solvent interaction. The 
overall result is increased bioavailability.9 
The objective of present study was to 
investigate effect of cyclodextrin garcinol complex 
(garcinol complex) on the isoproterenol induced 
cardiotoxicity and cardiac hypertrophy in rats with a 
purpose to assess it’s cardioprotective effect. 
 
Materials and Methods 
Animals 
Male Wistar albino rats (250-300 g) were 
obtained from National Toxicological Centre (NTC) 
Pune. Rats were housed under standard housing  
conditions of temperature (25 ºC), relative humidity 
(60%) and photo period of 12 h dark/12 h light. Pellet 
diet (Chakan Oil Mills, Pune, India) and water were 
provided ad libitum. All the protocols of animal 
experiments were approved by the Institutional 
Animal Ethics Committee (IAEC) (proposal no-
CPCSEA/31/2008) in accordance to the guidelines of 
Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA), 
Ministry of Social Justice and Empowerment, 
Government of India, New Delhi. 
 
Chemicals and sample 
Garcinol Complex were obtained as gift 
sample from Indus biotech private limited, Pune. 
Isoproterenol  was procured from Samarth life 
sciences private limited, Mumbai. Epinephrine 
hydrochloride, and malondialdehyde were purchased 
from Sigma Chemical Co., USA. Reduced glutathione 
(GSH), 5,5´-dithiobis (2-nitro benzoic acid) (DTNB) 
and thiobarbituric acid (TBA) were obtained from Hi 




Male Wistar rats (250-300g) were divided into 
following 4 groups of six animals each. Group1 was 
control (distilled water, 2 mL/kg/day orally for 18 
days and water for injection i.p. from day 9 to day 18), 
group 2 was cyclodextrin (cyclodextrin 2 mL/kg/day 
orally for 18 days and water for injection i.p. from day 
9 to day 18),  group 3 iso (distilled water, 2 
mL/kg/day orally for 18 days and isoproterenol 1 
mg/kg/day  i.p. from day 9 to day 18), group 4 
garcinol complex (garcinol complex 20 mg/kg/day 
orally for 18 days and isoproterenol 1 mg/kg/day by 
i.p. from day 9 to day 18). The changes in body weight 
were recorded daily. Garcinol complex (20 
mg/kg/day) in distilled water was administered orally 
to group 4 rats daily for 18 days. The dose was 
selected on the basis of previous pillot dose response 
study. To group 1 (distilled water 2 mL/kg) and group 
2 (cyclodextrin 2 mL/kg/day) was administered orally 
for 18 days. The control group received an 
intraperitoneal injection of sterile water (1 mL/kg for 
10 days) from 9th to 18th day. While group 2 and 
group 4 received isoproterenol (1 mg/kg for 10 days) 
from 9th to 18th day. After 24 hours of the last 
injection of isoproterenol and vehicle, the rats were 
anaesthetized by anesthetic ether.  
The ECG and heart rate were recorded using 
8 channels Power Lab System (AD Instruments Pty 
Ltd, Unit 13, 18-22 Lexington Drive, Bella Vista NSW 
2153, Australia).  The animals were sacrificed with 
overdose of anesthetic ether; the hearts were isolated 
and weighed. Heart from four animals were randomly 
selected for tissue parameter measurement.  
The heart of each animals were cut in to small 
pieces, placed in chilled 0.25 M sucrose solution and 
blotted on a filter paper. The tissues were 
homogenized in 10% chilled tris hydrochloride buffer 
(10 mM, pH 7.4) by tissue homogenizer (Remi 
Motors, Mumbai, India 400058) and centrifuged at 
7500 rpm for 15 minutes at 0ºC using Eppendorf 
5810-R high speed cooling centrifuge. The clear 
supernatant was used for the measurement of GSH 
and MDA content. 
 
Tissue parameters 
Lipid peroxidation assay (MDA content) 
Thiobarbituric acid-reactive substances 
(TBARS) was measured by method of Slater and 
Sawyer.10 To 2.0 mL of the tissue homogenate 
(supernatant) was added to 2.0 mL of freshly prepared 
10% w/v trichloroacetic acid (TCA) and the mixture 
was allowed to stand in an ice bath for 15 minutes. 
After 15 minutes, followed by centrifugation at 2500 
rpm for 10 minutes at 0 °C, two ml of clear 
supernatant solution was mixed with 2.0 ml of freshly 
prepared 0.67%w/v thiobarbituric acid. The resulting 
solution was heated in a boiling water bath for 10 
minutes. It was then immediately cooled in an ice bath 
for 5 minutes. The absorbance of colour developed 
was measured against reagent blank by UV/VIS 
spectrophotometer (JASCO-V-530, Japan) at 532 nm 
using 1, 1, 3, 3-tetraethoxypropane as a standard.  
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Measurement of GSH 
GSH was measured by method described by 
Moron et al.11 1.0 mL of tissue homogenate 
(supernatant) and 1 ml of 20%  trichloroacetic acid 
(TCA) were mixed and centrifuged at 2500 rpm for 15 
minutes at 0°C. In 0.25 mL of supernatant, 2 ml of 5, 
5´-dithiobis (2-nitro benzoic acid) (0.6M) reagent was 
added. The final volume was made up to 3 mL with 
phosphate buffer (pH 8.0). The colour developed was 
read at 412 nm against reagent blank. Different 
concentrations (10-50µg) of standard glutathione were 
processed as mentioned above for constructing 
standard curve. The amount of reduced glutathione 
was expressed as µg of GSH /gm of protein. 
 
Determination of organ weight ratio 
Body weight was the weight on the day of 
sacrifice of animal. Heart weight was recorded after 
keeping the heart in cold saline and squeezing out the 
blood. The weight of the left ventricle was recorded. 




The statistical analysis was performed by 
software package of graph pad prism (version 4.03). 
All values were expressed as mean ± SEM. One way 
ANOVA was applied to test for significance of 
biochemical data of different groups and multiple 
comparisons were determined by the Bonferroni Post 









Figure 1. Effect of garcinol complex (20 mg/kg) on QT and ST interval of male wistar rats 
in isoproterenol induced cardiotoxicity & cardiac hypertrophy. 
1) ECG of rat (control gp) on 0th day  
 
2) ECG of rat (Isoproterenol gp) on 18th day 
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Effect of garcinol complex on electrocardiograph of rats 
At post treatment, the mean (SEM) QT 
interval was significantly higher in the iso group 
compared with the control group (16.8 ± 0.0021 vs 
2.17 ± 0.0044 msec, respectively; P < 0.001); the ST 
interval was also significantly higher in the iso group 
(18 ± 0.0009 vs 1.7±0.0008 msec; P < 0.001). The QT 
and ST intervals were significantly lower in the 
garcinol complex (20 mg/kg) group compared with 
the iso group (5.4 ± 0.0013, P < 0.001 and 6.3 ± 
0.0008, P < 0.001, respectively). (Table 1 and Figure 
1). 
 
Effect of garcinol complex on heart rate of rats 
Heart rate was non-significantly higher in the 
iso group compared with the control group (43.66 ± 
6.267 vs 16.68 ± 1.667 beats/min). Heart rate was 
non-significantly lower in the garcinol complex (20 
mg/kg) group compared with the iso group (24.72 ± 
4.819 beats/min. Table 2). 
 
Effect of garcinol complex on myocardial MDA and GSH 
levels 
Myocardial MDA concentration was 
significantly higher in the iso group compared with the 
control group (4.443 ± 0.0392 vs 2.690 ± 0.2154 nM 
MDA/mg protein, respectively; P < 0.001). The MDA 
concentration was significantly lower in the garcinol 
complex (20 mg/kg) group compared with the iso 
group (3.47 ± 0.1646 nM MDA/mg protein; P < 
0.01). Myocardial GSH concentration was significantly 
lower in the ISO group compared with the control 
group (19.02 ± 0.8526 vs 27.50 ± 1.501μg GSH/mg 
protein; P < 0.01). Myocardial GSH concentration was 
significantly higher in the garcinol complex (20 
mg/kg) group than in the iso group (23.49 ± 1.471 μg 
GSH/mg protein; P < 0.05), (Table 3). 
 
Organ weight in treated with garcinol complex 
Heart to body weight ratio was significantly 
higher in the iso group compared with the control 
group (3.84 ± 0.08864 vs 3.84 ± 0.08864 mg/g, 
respectively; P < 0.001). Heart to body weight ratio 
was non significantly lower in the garcinol complex 
(20 mg/kg) group compared with the iso group (3.58 
± 0.0966 mg/g), (Table 4 and Figure 2).   







Iso- Isoproterenol  
[(n = 6), data are mean (SEM) msec.] 
### p<0.001 significant as compared with control group.  
*** p<0.001 significant as compared with isoproterenol group. 
### p<0.001 significant as compared with control group.  
*** p<0.001 significant as compared with Isoproterenol group. 









Garcinol Complex+Iso  
(20 mg/kg)  group (msec) 
 
QT 2.17 ± 0.0044 0.88 ± 0.00085 
16.8 ± 0.0021### 
 
5.4 ± 0.0013*** 
 
ST 1.7±0.0008 4.2 ± 0.0008 
18 ± 0.0009 ### 
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Iso- Isoproterenol, MDA- malondialdehyde, GSH- glutathione.  
[(n = 6), data are mean (SEM)] 
### p<0.001 significant as compared with control group.  
** p<0.01 significant as compared with isoproterenol group.  
## p<0.05 significant as compared with control group.  
ns- non significant as compared with Isoproterenol group.  
Iso: Isoproterenol.  
[(n = 6), data are mean (SEM)] 
ns: non significant as compared with control group.   
ns: non significant as compared with Isoproterenol group.  
 
 
Iso: Isoproterenol.  
[(n = 6), data are mean (SEM)]  
### p<0.001 significant as compared with control group.   
ns: non significant as compared with isoproterenol group. 
 
The results of present investigation clearly 
demonstrated that there was increase in myocardial 
injury as indicated by increase in QT and ST intervals 
of ECG pattern in isoproterenol treated group. 
Administration of garcinol complex along with 
isoproterenol (20 mg/kg) reduced QT and ST 
intervals close to control level.  
The electrocardiographic recording from this 
study indicate that, isoproterenol treatment 
significantly prolonged QT and ST intervals as 
compared to control group. The treatment with 
garcinol complex (20mg/kg) resulted in significant 
reduction of the QT and ST interval prolongation as 
compared to isoproterenol group. Thus indicating the 
cardioprotective nature of the garcinol complex. 
Administration of isoproterenol (1 mg/kg) 
caused a significant increase in MDA content (an 
index of lipid peroxidation) in cardiac tissues and 
decrease in myocardial GSH as compared to control 
group indicating an increase in oxidative stress. These 
results correlate with previous studies which have 
demonstrated the involvement of oxidative stress and 
lipid peroxidation in isoproterenol induced cardiac 
hypertrophy and cardiotoxicity.12, 13, 14 Administration 
of garcinol complex (20 mg/kg) improved the 
biochemical marker levels indicating decrease in 
oxidative stress as evident by increased level of GSH 
with decreased lipid peroxidation (MDA value). 
In isoproterenol (1 mg/kg for 10 days) treated 
rats there was significant increase in MDA content (an 
index of lipid peroxidation) and the significant 
reduction of biological antioxidant enzymes like GSH 
levels in cardiac tissues indicating the oxidative stress. 
The results showed that the treatment with garcinol 
complex significantly increased the GSH levels and 








Garcinol Complex+ Iso 
(20 mg/kg)  group 
 
MDA, nM/mg protein 
2.690 ± 0.2154 
 
4.130 ± 0.1468 
 
4.443 ± 0.0392 ### 
 
3.47 ± 0.1646 ** 
 
GSH, μg/mg protein 27.50 ± 1.501 
20.37± 0.8556 
 
19.02 ± 0.8526 ## 23.49 ± 1.471 * 
 








Garcinol Complex+ Iso 




16.68 ± 1.667 
 
9.117 ± 7.189 43.66 ± 6.267 ns 24.72 ± 4.819 ns 








Garcinol Complex+Iso  
(20 mg/kg)  group 
 
Heart to body 
weight mg/g 
3.19 ± 0.066 
 
3.22 ± 0.0427 
 
3.84 ± 0.08864 ### 
 
3.58 ± 0.0966 ns 
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decreased the MDA level, thus indicating a 
cardioprotective effect of garcinol complex.  
The plant phenolic compounds and 
flavonoids provide defense against oxidative stress.15 
Flavonoids act as good antioxidants because of their 
free radical scavenging activity and protect tissue 
against free radical mediated lipid peroxidation and 
also chelate metal ions.16 Garcinol is a potent 
antioxidant present in G. indica which has structural 
similarity to curcumin as it contains both phenolic 
hydroxyl group as well as a β-diketone moiety. It is a 
free radical scavenger.17, 18  In our study, 
administration of garcinol complex in a dose of 20 
mg/kg for 18 days restored the altered parameters 
produced by isoprotenol. 
A recently published study by Kumar and 
coworkers19 showed cardio protective effect of 




It is thus concluded that garcinol complex (20 
mg/kg) administration offered significant protection 
against isoproterenol induced cardiotoxicity and 
cardiac hypertrophy as well as decreased myocardial 
injury by preservation of endogenous antioxidants and 
reduction of lipid peroxidation in rat heart. 
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